Ming Cui
Impact in
- Nephrology top 5%
- Parathyroid Disorders and Treatments
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 40
- Pancreatic and Hepatic Oncology Research 25
- Colorectal Cancer Surgical Treatments 10
-
- Epigenetics and DNA Methylation 7
- Glycosylation and Glycoproteins Research 6
- Co-authors
- Yupei Zhao (22 shared papers)Lei You (9 shared papers)Bo Ren (1 shared paper)Gang Yang (1 shared paper)Huanyu Wang (1 shared paper)Mengyu Feng (1 shared paper)Quan Liao (11 shared papers)Jinlan Zhang (2 shared papers)
- Journals
- Cancer Letters (6 papers)Frontiers in Oncology (3 papers)BMC Surgery (3 papers)Scientific Reports (3 papers)Oncotarget (3 papers)
- Partner nations
- ChinaUnited StatesEthiopia
In The Last Decade
Ming Cui
104 papers receiving 2.2k citations
Ming Cui's Hit Papers
Peers
Comparison fields: 5 of 113
- Nephrology 184
- Oncology 671
- Cancer Research 352
- Complementary and alternative medicine 173
- Hepatology 121
Countries citing papers authored by Ming Cui
This map shows the geographic impact of Ming Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Cui more than expected).
Fields of papers citing papers by Ming Cui
This network shows the impact of papers produced by Ming Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Cui. The network helps show where Ming Cui may publish in the future.
Co-authors
The 25 scholars most cited alongside Ming Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 112 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tumor microenvironment participates in metastasis of pancreatic cancer Hit paper breakdown → | 2018 | 432 |
| 2 | 2004 | 187 | |
| 3 | 2016 | 113 | |
| 4 | 2022 | 99 | |
| 5 | 2021 | 62 | |
| 6 | 2010 | 61 | |
| 7 | 2021 | 61 | |
| 8 | 2008 | 55 | |
| 9 | 2018 | 54 | |
| 10 | 2016 | 53 | |
| 11 | 2020 | 47 | |
| 12 | 2020 | 46 | |
| 13 | 2004 | 36 | |
| 14 | 2020 | 35 | |
| 15 | 2024 | 31 | |
| 16 | 2016 | 31 | |
| 17 | 2018 | 28 | |
| 18 | 2021 | 28 | |
| 19 | 2017 | 27 | |
| 20 | 2020 | 27 |
About Ming Cui
Ming Cui is a scholar working on Oncology, Molecular Biology, Surgery, Nephrology and Cancer Research, having authored 112 papers that have together received 2.2k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (25 papers), Parathyroid Disorders and Treatments (13 papers), Colorectal Cancer Surgical Treatments (10 papers), Epigenetics and DNA Methylation (7 papers), Glycosylation and Glycoproteins Research (6 papers), Cancer Genomics and Diagnostics (5 papers), Neuroendocrine Tumor Research Advances (5 papers) and Immune cells in cancer (4 papers). The work is most often cited by research in Nephrology (184 citations), Oncology (671 citations), Cancer Research (352 citations), Complementary and alternative medicine (173 citations) and Hepatology (121 citations). Ming Cui has collaborated with scholars based in China, United States and Ethiopia. Frequent co-authors include Yupei Zhao, Lei You, Bo Ren, Gang Yang, Huanyu Wang, Mengyu Feng, Quan Liao, Jinlan Zhang, De‐an Guo and Xiang Zhang. Their work appears in journals such as Cancer Letters, Frontiers in Oncology, BMC Surgery, Scientific Reports and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.